Pediatric Exclusivity Would Be Reduced To Three Months Under Bipartisan Bill

The Lower PRICED Drugs Act from Sens. Lott (R-Miss.) and Stabenow (D-Mich.) also proposes to expand generic competition to non-“Orange Book”-listed antibiotics and to revise how 30-month stays are applied.